Rose bengal is an
anionic dye considered as a potential photosensitizer
for anticancer photodynamic therapy. The clinical utility of rose
bengal is hampered by its short half-life, limited transmembrane transport,
aggregation, and self-quenching; consequently, efficient drug carriers
that overcome these obstacles are urgently required. In this study,
we performed multilevel
in vitro
and
in silico
characterization of interactions between rose bengal and cationic
poly(amidoamine) (PAMAM) and poly(propyleneimine) (PPI) dendrimers
of the third and fourth generation and assessed the ability of the
resultant complexes to modulate the photosensitizing properties of
the drug. We focused on explaining the molecular basis of this phenomenon
and proved that the generation- and structure-dependent binding of
the dye by the dendrimers increases the cellular uptake and production
of singlet oxygen and intracellular reactive oxygen species, leading
to an increase in phototoxicity. We conclude that the application
of dendrimer carriers could enable the design of efficient photodynamic
therapies based on rose bengal.